Tidewater Inc. (NYSE:TDW) (the "Company" or "Tidewater") today announced the pricing of its registered underwritten public offering of 3,987,914shares of its common stock at a public offering price
ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that it has entered into a securities purchase agreement with a single institutional
Ares Capital Corporation (NASDAQ: ARCC) announced that it has priced a public offering of 8,000,000 shares of its common stock. Ares Capital has granted the underwriters an option to purchase up to an additional 1,200,000 shares of common stock.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the pricing of its underwritten public offering of
LSB Industries, Inc. (NYSE:LXU) ("LSB" or the "Company") today announced the pricing of the previously announced underwritten public offering (the "Offering") by an affiliate of Eldridge
Roivant Sciences Ltd. (NASDAQ:ROIV), a next-generation biopharmaceutical company dedicated to improving the delivery of healthcare to patients, announced today the commencement of a proposed underwritten public offering
AmerisourceBergen Corporation (NYSE: ABC) (the "Company") announced today a secondary public offering of 10 millionsharesof common stock of the Company held by Walgreens Boots Alliance Holdings LLC (theAmerisourceBergen Corporation (NYSE:ABC) (the &
Ares Capital Corporation (NASDAQ:ARCC) announced that it plans to make a public offering of 8,000,000 shares of its common stock. Ares Capital also plans to grant the underwriters an option to purchase up to an